期刊文献+

左旋卡尼汀治疗慢性心功能不全疗效观察 被引量:2

Curative effect observation of L-carnitine in the treatment of patients with chronic heart dysfunction
暂未订购
导出
摘要 目的:观察左旋卡尼汀对慢性心功能不全的治疗效果。方法:选择慢性心功能不全患者40例,随机分为两组,每组20例。对照组给予常规的心衰治疗,治疗组在此基础上加用左旋卡尼汀3.0 g/d静点,1次/d,疗程14 d。观察治疗前后心功能状况和药物不良反应。结果:①两组治疗后均有效;②治疗组的总有效率高于对照组(P<0.05),心功能改善更为显著(P<0.05),且未见不良反应。结论:慢性心功能不全患者在常规治疗下适量加用左旋卡尼汀能明显改善心功能。 Objective: To observe the effect of L-carnitine on chronic heart dysfunction.Methods: 80 patients with chronic heart dysfunction were divided into two groups randomly,20 patients in each group.The control group were treated with conventional heart failure therapy.The treatment group were treated with conventional therapy and L-carnitine 3.0 g/d ivgtt,once a day,course of treatment for 14 days.The heart function and the side effects before and after treatment were observed.Results: ①There were effective after treatment in two groups;②the total effective rate in the treatment group was superior to that in the control group(P〈0.05),and the improvement of cardiac function was even more significant than the control group(P〈0.05),and no side-effect was observed.Conclusion: Added L-carnitine under conventional treatment is beneficial to improve the cardiac function in the treatment of patients with chronic heart dysfunction.
出处 《中国医药导报》 CAS 2010年第32期63-64,共2页 China Medical Herald
关键词 左旋卡尼汀 慢性心功能不全 疗效 L-carnitine Chronic heart dysfunction Curative effect
  • 相关文献

参考文献5

二级参考文献62

  • 1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:91
  • 2季先友.左卡尼汀治疗缺血性心肌病心衰的疗效观察[J].齐齐哈尔医学院学报,2007,28(2):132-134. 被引量:10
  • 3Kosmicki M.Metabolic drugs in treatment of ischaemic heart disease[J].Doctros Cuide,2001(1):57-64
  • 4Yusuf S,Sleight P,P Ogue J,et al.Effects of angiotensin-converting enzyme,ramipil,on cardiovascular events in high Orisk patients The HeartOutcomes Prevention Evaluation Study Investigators[J].N Englj Med,2000,324(3):145-153
  • 5PottB,Zannad F,Remme WJ,et al.The effect of spironolactone on morbidiy and mortaliy in patientswith severe heart failure[J].N Englj Med,1999,341:709-717
  • 6Bristow MR.Nengl J Mcd,1984,311(7):850
  • 7Pierpont M,ct al.Am J Ccrdiol,1989,64(5):56
  • 8Rizos I.Three-year survival of patients with heat failure caused by dilated cardiomyopathy and L-camitine administration[J].Am Heat J,2000,139(2pt3):120-123
  • 9Calvani M,Reda E,Arrigoni Martelli E.Regulation by camitine of myocardial faty acid and carbohydrate metabolism under normal and pathological conditions[J].Basic Res Cardiol,2000,95(2):75-83
  • 10Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L

共引文献3786

同被引文献15

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部